Recombinant Anti-PlGF Antibody (V3S-1022-YC575) (CAT#: V3S-1022-YC575)

Send Inquiry
  • fig1
    Figure 1 Anti-PIGF Monoclonal Antibody (V3S-1022-YC575) in WB
  • fig1
    Figure 2 Anti-PIGF Monoclonal Antibody (V3S-1022-YC575) in DB
  • fig1
    Figure 3 Anti-PIGF Monoclonal Antibody (V3S-1022-YC575) in ELISA

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a recombinant mouse antibody provided by CreativeBiolabs. The antibody is specific for Placental growth factor, Placental growth factor is a protein that in humans is encoded by the PGF gene. It can be used for PlGF detection in Enzyme-Linked Immunosorbent Assay. It was expressed in mammalian cells (293F or CHO) with antibody encoding genes and purified by affinity chromatography. Each lot of this antibody is quality control tested by SDS-PAGE and SEC-HPLC analysis. For highly sensitive assays, we recommend the ultrapurified form of the product, which has a lower endotoxin limit than standard antibody, less than 1 EU/mg or even 0.1 EU/mg.
Clonality Monoclonal
Host Species Mouse
Target Species Human
Isotype IgG

Property

Expression Species HEK293F or CHO Cell line
Conjugation Unconjugated, also available for Biotin, HRP, FITC and PE-labeled form.
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Purified with Protein A or G affinity chromatography
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application WB; DB; ELISA

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target PlGF
Alternative Name Placental growth factor; PlGF; PGF
Research Area Signal Pathway

Tested Data

WB

Figure 1 Anti-PIGF Monoclonal Antibody (V3S-1022-YC575) in WB

Western blot analysis of V3S-1022-YC575 was performed by loading human PIGF protein in reduced condition Lane 1, Lane 2 and Lane 3 (0.1 μg, 0.3 μg and 0.6 μg respectively) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with V3S-1022-YC575 (2 μg/mL) and HRP-conjugated goat anti-mouse IgG as a secondary antibody (1: 5000). Chemiluminescent detection was performed.

Figure 1 Anti-PIGF Monoclonal Antibody (V3S-1022-YC575) in WB

DB

Figure 2 Anti-PIGF Monoclonal Antibody (V3S-1022-YC575) in DB

Dot Blot analysis of V3S-1022-YC575 was performed by coating with human PIGF protein.

V3S-1022-YC575 incubation concentration: 2 μg/mL.
HRP-conjugated goat anti-mouse IgG as a secondary antibody (1: 6000)
NC: Negative control PC: Positive control

Figure 2 Anti-PIGF Monoclonal Antibody (V3S-1022-YC575) in DB

ELISA

Figure 3 Anti-PIGF Monoclonal Antibody (V3S-1022-YC575) in ELISA

ELISA analysis of V3S-1022-YC575 was performed by coating with human PIGF protein. Then blocked with BSA and incubated with V3S-1022-YC575. The HRP-conjugated goat anti-mouse IgG as a secondary antibody (1: 2000). Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 3 Anti-PIGF Monoclonal Antibody (V3S-1022-YC575) in ELISA

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry